This article has been updated with information from Foundation Medicine's earnings call.
NEW YORK (GenomeWeb) – Foundation Medicine reported a 45 percent rise in revenues for the third quarter after the close of the market on Wednesday, driven by increases in both its clinical testing and biopharmaceutical businesses.